| Trial Status | Recruiting |
| Dates | Date of activation: 19-Mar-02 |
| Data management at EORTC | Full |
| Phase | 3 |
| Randomized trial | Yes |
| Type | Neoadjuvant |
| Targeted Sample size | 686 |
| Number of steps | 1 |
| Drug | Cisplatin |
| Study Staff | Alessandro Colombo (Study Coordinator) - Ospedale Alessandro Manzoni, Lecco Gemma Kenter (Study Coordinator) - Academisch Medisch Centrum - Universiteit van Amsterdam, Amsterdam Fabio Landoni (Study Coordinator) - Istituto Europeo Di Oncologia, Milano Corneel Coens (Statistician) - EORTC Headquarters, Brussels Maarten De Rouck (Data Manager) - EORTC Headquarters, Brussels Sandrine Marreaud (Coordinating Physician) - EORTC Headquarters, Brussels Liesbeth Knaepen (Project Manager) - EORTC Headquarters, Brussels, liesbeth.knaepen( at )eortc.be, +32 27741082 |
| Type of cancer | Cervical |
| Participating Groups | EORTC Gynecological Cancer Group(Coordinating Group) |
| Centers authorized by EORTC | Kaiser Franz Josef Spital (Vienna, Austria) - Inst. 822 Medical University of Graz (Graz, Austria) - Inst. 908 Universitair Ziekenhuis Antwerpen (Edegem, Belgium) - Inst. 117 Centre Hospitalier Regional De La Citadelle (Liege, Belgium) - Inst. 145 U.Z. Leuven - Campus Gasthuisberg (Leuven, Belgium) - Inst. 147 Centre Regional Francois Baclesse (Caen, France) - Inst. 206 CHU de Grenoble - La Tronche - Hôpital A. Michallon (Grenoble, France) - Inst. 215 Clinica Universita (Torino, Italy) - Inst. 712 Ospedale Di Circolo E Fondazione Macchi (Varese, Italy) - Inst. 715 Ospedale San Gerardo (Monza, Italy) - Inst. 775 Istituto Europeo Di Oncologia (Milano, Italy) - Inst. 3869 Ospedale Mauriziano Umberto I (Torino, Italy) - Inst. 3902 Hospitais Da Universidade De Coimbra (Coimbra, Portugal) - Inst. 5900 Hospital Universitario San Carlos (Madrid, Spain) - Inst. 366 Erasmus MC - Daniel den Hoed Cancer Center (Rotterdam, The Netherlands) - Inst. 302 Radboud University Nijmegen Medical Centre (Nijmegen, The Netherlands) - Inst. 304 Universitair Medisch Centrum - Academisch Ziekenhuis (Utrecht, The Netherlands) - Inst. 306 Vrije Universiteit Medisch Centrum (Amsterdam, The Netherlands) - Inst. 308 Leiden University Medical Centre (Leiden, The Netherlands) - Inst. 310 Medisch Spectrum Twente (Enschede, The Netherlands) - Inst. 317 Academisch Medisch Centrum - Universiteit van Amsterdam (Amsterdam, The Netherlands) - Inst. 342 NHS Greater Glasgow and Clyde - Beatson West of Scotland Cancer Centre - Gartnavel General Hospital (Glasgow, United Kingdom) - Inst. 6982 Maidstone & Tunbridge Wells NHS Trust - Maidstone Hospital (Maidstone, United Kingdom) - Inst. 7039 East Kent Hospitals University NHS Foundation Trust - Queen Elizabeth The Queen Mother Hospital (Margate (kent), United Kingdom) - Inst. 7095 |
| Protocol summary | Cancer.gov (PDQ) ClinicalTrials.gov |
| NCT number | NCT00039338 |
| EudraCT | 2008-003396-52 |
| Protocol documents in PDF (requires password) | Study documentation |